Exact Mass: 390.0529
Exact Mass Matches: 390.0529
Found 32 metabolites which its exact mass value is equals to given mass value 390.0529,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-(5-carboxy-7-methoxy-1,3-benzodioxol-4-yl)-7-methoxy-1,3-benzodioxole-5-carboxylic acid
4-(5-carboxy-7-methoxy-1,3-benzodioxol-4-yl)-7-methoxy-1,3-benzodioxole-5-carboxylic acid
1,2-BIS[3-(TRIFLUOROMETHYL)PHENYL]-1,1,2,2-TETRAFLUOROETHANE 97
1,2-BIS[3-(TRIFLUOROMETHYL)PHENYL]-1,1,2,2-TETRAFLUOROETHANE 97
6-BROMO-4-(2-(PYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE
6-BROMO-4-(2-(PYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE
methyl (2Z)-5-(4-chlorobenzoyl)-2-(dimethylaminomethylidene)-3-oxopyrrolo[2,1-b][1,3]thiazole-7-carboxylate
methyl (2Z)-5-(4-chlorobenzoyl)-2-(dimethylaminomethylidene)-3-oxopyrrolo[2,1-b][1,3]thiazole-7-carboxylate
glucoconringiin(1-)
glucoconringiin(1-)
An hydroxy-alkylglucosinolate that is isobutylglucosinolate which has been hydroxylated at the 2-position of the isobutyl chain.
A3373
A3373
A3373, a novel chemical inhibitor of Phospholipase D1 (PLD1) and PLD2, with IC50 of 325 nM and 15.15?μM, respectively, inhibits LPS-induced immune response and plays important roles in autoimmune arthritis, bone demineralization and osteoclastogenesis[1][2].
2-[3,4-dihydroxy-5-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
2-[3,4-dihydroxy-5-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
5,13,17-trihydroxy-4,12-bis(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-9,15-dione
5,13,17-trihydroxy-4,12-bis(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-9,15-dione
2-[2,5-dihydroxy-3-(2,4,6-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
2-[2,5-dihydroxy-3-(2,4,6-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
(2r)-2,3-bis(formyloxy)propoxy([(2r,3r,5s,6r)-2,3,4,5,6-pentahydroxycyclohexyl]oxy)phosphinic acid
(2r)-2,3-bis(formyloxy)propoxy([(2r,3r,5s,6r)-2,3,4,5,6-pentahydroxycyclohexyl]oxy)phosphinic acid
6,12-dihydroxy-5,7,13,14-tetramethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
6,12-dihydroxy-5,7,13,14-tetramethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
2-[3,5-dihydroxy-4-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
2-[3,5-dihydroxy-4-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
(3s,6s)-3,6-bis[(2r)-3,3-dichloro-2-methylpropyl]-1,4-dimethylpiperazine-2,5-dione
(3s,6s)-3,6-bis[(2r)-3,3-dichloro-2-methylpropyl]-1,4-dimethylpiperazine-2,5-dione
2,3-bis(formyloxy)propoxy([(2r,3s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy)phosphinic acid
2,3-bis(formyloxy)propoxy([(2r,3s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy)phosphinic acid
2-[3,5-dihydroxy-2-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
2-[3,5-dihydroxy-2-(3,4,5-trihydroxyphenoxy)phenoxy]benzene-1,3,5-triol
(3r,6r)-3,6-bis[(2s)-3,3-dichloro-2-methylpropyl]-1,4-dimethylpiperazine-2,5-dione
(3r,6r)-3,6-bis[(2s)-3,3-dichloro-2-methylpropyl]-1,4-dimethylpiperazine-2,5-dione
3-formyl-6-[(3-formyl-2,4-dihydroxy-6-methylbenzoyloxy)methyl]-2,4-dihydroxybenzoic acid
3-formyl-6-[(3-formyl-2,4-dihydroxy-6-methylbenzoyloxy)methyl]-2,4-dihydroxybenzoic acid
